8DLF
 
 | |
6VH6
 | |
5T7X
 | | Crystal structure of HHV-4 EBNA1 DNA binding domain (patient-derived, nasopharyngeal carcinoma) bound to DNA | | Descriptor: | DNA (5'-D(*GP*GP*AP*TP*AP*GP*CP*CP*TP*AP*TP*GP*CP*TP*AP*CP*CP*C)-3'), DNA (5'-D(*GP*GP*GP*TP*AP*GP*CP*AP*TP*AP*GP*GP*CP*TP*AP*TP*CP*C)-3'), Epstein-Barr nuclear antigen 1 | | Authors: | Malecka, K.A, Messick, T.E, Lieberman, P.M. | | Deposit date: | 2016-09-06 | | Release date: | 2017-07-19 | | Last modified: | 2023-10-04 | | Method: | X-RAY DIFFRACTION (2.35 Å) | | Cite: | Carcinoma-risk variant of EBNA1 deregulates Epstein-Barr Virus episomal latency.
Oncotarget, 8, 2017
|
|
6PW2
 | |
5KDM
 | |
4K2J
 | |
5W2L
 | | Structure of a central domain of human Ctc1 | | Descriptor: | CST complex subunit CTC1, MERCURY (II) ION | | Authors: | Rice, C, Skordalakes, E. | | Deposit date: | 2017-06-06 | | Release date: | 2017-11-29 | | Last modified: | 2024-03-13 | | Method: | X-RAY DIFFRACTION (1.86 Å) | | Cite: | Structural and functional analysis of an OB-fold in human Ctc1 implicated in telomere maintenance and bone marrow syndromes.
Nucleic Acids Res., 46, 2018
|
|
5WMF
 | |
6NPP
 | |
6NPM
 | |
6NPI
 | | Crystal structure of Epstein-Barr Virus Nuclear Antigen-1, EBNA1, bound to fragments | | Descriptor: | ({2-[(4-bromo-5-methyl-1,2-oxazol-3-yl)amino]-2-oxoethyl}sulfanyl)acetic acid, 2-pyrrol-1-ylbenzoic acid, Epstein-Barr nuclear antigen 1 | | Authors: | Messick, T.E. | | Deposit date: | 2019-01-17 | | Release date: | 2019-03-20 | | Last modified: | 2023-10-11 | | Method: | X-RAY DIFFRACTION (1.501 Å) | | Cite: | Structure-based design of small-molecule inhibitors of EBNA1 DNA binding blocks Epstein-Barr virus latent infection and tumor growth.
Sci Transl Med, 11, 2019
|
|
